A detailed history of Susquehanna International Group, LLP transactions in Volitionrx LTD stock. As of the latest transaction made, Susquehanna International Group, LLP holds 50,076 shares of VNRX stock, worth $30,546. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50,076
Previous 23,000 117.72%
Holding current value
$30,546
Previous $16,000 137.5%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$0.72 - $1.19 $36,054 - $59,590
50,076 New
50,076 $38,000
Q1 2023

May 16, 2023

BUY
$1.54 - $2.68 $99,671 - $173,454
64,722 Added 134.36%
112,894 $215,000
Q4 2022

Feb 14, 2023

SELL
$1.63 - $2.6 $43,188 - $68,889
-26,496 Reduced 35.49%
48,172 $117,000
Q3 2022

Nov 14, 2022

BUY
$1.57 - $2.38 $14,313 - $21,698
9,117 Added 13.91%
74,668 $102,000
Q2 2022

Aug 15, 2022

BUY
$1.96 - $3.05 $1,191 - $1,854
608 Added 0.94%
65,551 $134,000
Q1 2022

May 16, 2022

SELL
$2.41 - $3.24 $28,936 - $38,902
-12,007 Reduced 15.6%
64,943 $195,000
Q4 2021

Feb 14, 2022

BUY
$3.02 - $4.13 $19,252 - $26,328
6,375 Added 9.03%
76,950 $242,000
Q3 2021

Nov 15, 2021

BUY
$2.98 - $3.48 $46,312 - $54,082
15,541 Added 28.24%
70,575 $219,000
Q2 2021

Aug 11, 2021

SELL
$3.01 - $3.78 $32,288 - $40,548
-10,727 Reduced 16.31%
55,034 $181,000
Q1 2021

May 17, 2021

BUY
$3.33 - $6.5 $132,940 - $259,493
39,922 Added 154.5%
65,761 $249,000
Q4 2020

Feb 16, 2021

BUY
$2.88 - $4.33 $16,666 - $25,057
5,787 Added 28.86%
25,839 $101,000
Q3 2020

Nov 16, 2020

BUY
$2.94 - $4.05 $58,952 - $81,210
20,052 New
20,052 $64,000
Q1 2019

May 15, 2019

SELL
$2.19 - $3.45 $64,366 - $101,398
-29,391 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$1.7 - $2.88 $49,964 - $84,646
29,391 New
29,391 $53,000

Others Institutions Holding VNRX

About VOLITIONRX LTD


  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.